Samantha E. Dilworth

机构：University of California, San Francisco, University of San Francisco · ORCID：0000-0002-5451-5486

发表论文 120 篇 · 总被引 2957 次 · h-index 32

代表论文

• Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia (2024 · Clinical Infectious Diseases · 被引 47)
• Policy Recommendations to Support Equitable Access to Long-Acting Injectables for HIV Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association (2024 · Clinical Infectious Diseases · 被引 18)
• Patient Attitudes Toward Self- or Partner-, Friend-, or Family-Administered Long-acting Injectable Antiretroviral Therapy: A Mixed-Methods Study Across 3 Urban Human Immunodeficiency Virus Clinics (2024 · Open Forum Infectious Diseases · 被引 12)
• A positive affect intervention alters leukocyte DNA methylation in sexual minority men with HIV who use methamphetamine (2024 · Brain Behavior and Immunity · 被引 10)
• Identifying Preferred Program Delivery Attributes for Long-Acting Injectable Cabotegravir-Rilpvirine in Three US HIV Clinics: A Discrete-Choice Experiment (2025 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 6)
• Discontinuation of Long-acting Injectable Cabotegravir–Rilpivirine in a Large Clinic Cohort (2025 · Open Forum Infectious Diseases · 被引 3)